1. Home
  2. IINN vs YI Comparison

IINN vs YI Comparison

Compare IINN & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspira Technologies Oxy B.H.N. Ltd.

IINN

Inspira Technologies Oxy B.H.N. Ltd.

HOLD

Current Price

$0.94

Market Cap

35.3M

Sector

Health Care

ML Signal

HOLD

Logo 111 Inc.

YI

111 Inc.

HOLD

Current Price

$2.90

Market Cap

38.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IINN
YI
Founded
2018
2010
Country
Israel
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Retail-Drug Stores and Proprietary Stores
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
35.3M
38.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IINN
YI
Price
$0.94
$2.90
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
174.4K
16.8K
Earning Date
10-01-2025
12-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$289,000.00
$1,908,028,152.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2,582.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$2.48
52 Week High
$1.65
$11.35

Technical Indicators

Market Signals
Indicator
IINN
YI
Relative Strength Index (RSI) 42.63 36.83
Support Level $0.92 $2.60
Resistance Level $1.12 $3.00
Average True Range (ATR) 0.06 0.25
MACD -0.01 -0.02
Stochastic Oscillator 25.04 28.17

Price Performance

Historical Comparison
IINN
YI

About IINN Inspira Technologies Oxy B.H.N. Ltd.

Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Share on Social Networks: